GT200200233A - Derivados de piridona de benzotiazol - Google Patents
Derivados de piridona de benzotiazolInfo
- Publication number
- GT200200233A GT200200233A GT200200233A GT200200233A GT200200233A GT 200200233 A GT200200233 A GT 200200233A GT 200200233 A GT200200233 A GT 200200233A GT 200200233 A GT200200233 A GT 200200233A GT 200200233 A GT200200233 A GT 200200233A
- Authority
- GT
- Guatemala
- Prior art keywords
- piridona
- benzotiazol
- derivatives
- ansikpres
- alzhpres
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Pain & Pain Management (AREA)
- Psychiatry (AREA)
- Pulmonology (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Psychology (AREA)
- Anesthesiology (AREA)
- Hospice & Palliative Care (AREA)
- Addiction (AREA)
- Immunology (AREA)
- Physical Education & Sports Medicine (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
LA PRESENTE INVENCION SE REFIERE A DERIVADOS DE PIRIDONA DE BENZOTIAZOL DE FORMULA GENERAL (I) EN DONDE R ES UN GRUPO FUNCIONAL DESCRITO EN EL EXPEDIENTE. ESTOS COMPUESTOS SON LIGANDOS DE RECEPTORES DE LA ADENOSINA QUE MODULA UN AMPLIO MARGEN DE FUNCIONES FISIOLOGICAS MEDIANTE LA INTERACCION CON RECEPTORES ESPECIFICOS DE LA SUPERFICIE DE LAS CELULAS POR LO QUE SON DE UTILIDAD EN UNA AMPLIA VARIEDAD DE CASOS TALES COMO ALZHEIMER, PARKINSON, ANSIEDAD, DEPRESION, ADICCION A LAS DROGAS, ENTRE OTROS QUE SE MENCIONAN EN LA SOLICITUD.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP01127313 | 2001-11-19 |
Publications (1)
Publication Number | Publication Date |
---|---|
GT200200233A true GT200200233A (es) | 2003-06-17 |
Family
ID=8179264
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GT200200233A GT200200233A (es) | 2001-11-19 | 2002-11-18 | Derivados de piridona de benzotiazol |
Country Status (21)
Country | Link |
---|---|
US (1) | US6599901B1 (es) |
EP (1) | EP1448196B1 (es) |
JP (1) | JP4216192B2 (es) |
KR (1) | KR100577109B1 (es) |
CN (1) | CN100346792C (es) |
AR (1) | AR037528A1 (es) |
AT (1) | ATE306265T1 (es) |
AU (1) | AU2002366194B8 (es) |
BR (1) | BR0214221A (es) |
CA (1) | CA2467551A1 (es) |
DE (1) | DE60206652T2 (es) |
ES (1) | ES2249639T3 (es) |
GT (1) | GT200200233A (es) |
MX (1) | MXPA04004683A (es) |
PA (1) | PA8557901A1 (es) |
PE (1) | PE20030715A1 (es) |
PL (1) | PL369470A1 (es) |
RU (1) | RU2295523C2 (es) |
TW (1) | TW200407137A (es) |
UY (1) | UY27543A1 (es) |
WO (1) | WO2003043634A1 (es) |
Families Citing this family (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SE521512C2 (sv) | 2001-06-25 | 2003-11-11 | Niconovum Ab | Anordning för administrering av en substans till främre delen av en individs munhåla |
US6727247B2 (en) * | 2001-12-10 | 2004-04-27 | Hoffman-La Roche Inc. | Substituted benzothiazole amide derivatives |
NO346973B1 (en) | 2002-12-20 | 2023-03-20 | Niconovum Ab | A physically and chemically stable nicotine-containing particulate material |
BRPI0414266A (pt) * | 2003-09-19 | 2006-11-07 | Hoffmann La Roche | derivados de tiazolopiridina como ligandos receptores da adenosina |
CA2543707A1 (en) | 2003-10-31 | 2005-05-19 | Takeda Pharmaceutical Company Limited | Nitrogen-containing fused heterocyclic compounds |
ATE457986T1 (de) * | 2004-07-22 | 2010-03-15 | Hoffmann La Roche | Benzothiazolderivate |
MX2007000635A (es) * | 2004-07-22 | 2007-03-07 | Hoffmann La Roche | Benzotiazoles sustituidos. |
ES2273599B1 (es) * | 2005-10-14 | 2008-06-01 | Universidad De Barcelona | Compuestos para el tratamiento de la fibrilacion auricular. |
US9402809B2 (en) | 2006-03-16 | 2016-08-02 | Niconovum Usa, Inc. | Snuff composition |
WO2008063301A2 (en) * | 2006-10-11 | 2008-05-29 | Alpharma, Inc. | Pharmaceutical compositions |
ES2398312T3 (es) * | 2007-04-04 | 2013-03-15 | Merck Sharp & Dohme Corp. | Agentes terapéuticos |
US9549909B2 (en) | 2013-05-03 | 2017-01-24 | The Katholieke Universiteit Leuven | Method for the treatment of dravet syndrome |
SG10202005916QA (en) | 2015-12-22 | 2020-07-29 | Zogenix International Ltd | Fenfluramine compositions and methods of preparing the same |
AU2016379345B2 (en) | 2015-12-22 | 2020-09-17 | Zogenix International Limited | Metabolism resistant fenfluramine analogs and methods of using the same |
AU2017315273B2 (en) | 2016-08-24 | 2021-04-29 | Zogenix International Limited | Formulation for inhibiting formation of 5-HT 2B agonists and methods of using same |
US10682317B2 (en) | 2017-09-26 | 2020-06-16 | Zogenix International Limited | Ketogenic diet compatible fenfluramine formulation |
EP3790537A1 (en) | 2018-05-11 | 2021-03-17 | Zogenix International Limited | Compositions and methods for treating seizure-induced sudden death |
EP3806835A1 (en) * | 2018-06-14 | 2021-04-21 | Zogenix International Limited | Compositions and methods for treating respiratory depression with fenfluramine |
DE102019110904B4 (de) | 2019-04-26 | 2022-01-20 | Helmholtz-Zentrum Dresden - Rossendorf E. V. | N-(4-methoxy-7-morpholinobenzo[d]thiazol-2-yl)-acetamid-Derivate und deren Verwendung |
US11612574B2 (en) | 2020-07-17 | 2023-03-28 | Zogenix International Limited | Method of treating patients infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3374550D1 (en) | 1982-12-21 | 1987-12-23 | Johnsen Jorgensen Plastics Ltd | Dispensing container |
EP1303272B1 (en) * | 2000-06-21 | 2008-02-13 | F. Hoffmann-La Roche Ag | Benzothiazole derivatives for the treatment of alzheimer's disease and parkinson's disease |
-
2002
- 2002-11-05 US US10/288,531 patent/US6599901B1/en not_active Expired - Fee Related
- 2002-11-09 WO PCT/EP2002/012543 patent/WO2003043634A1/en active IP Right Grant
- 2002-11-09 EP EP02803360A patent/EP1448196B1/en not_active Expired - Lifetime
- 2002-11-09 JP JP2003545315A patent/JP4216192B2/ja not_active Expired - Fee Related
- 2002-11-09 CN CNB028228901A patent/CN100346792C/zh not_active Expired - Fee Related
- 2002-11-09 BR BR0214221-0A patent/BR0214221A/pt not_active IP Right Cessation
- 2002-11-09 KR KR1020047007646A patent/KR100577109B1/ko not_active IP Right Cessation
- 2002-11-09 AT AT02803360T patent/ATE306265T1/de not_active IP Right Cessation
- 2002-11-09 PL PL02369470A patent/PL369470A1/xx not_active Application Discontinuation
- 2002-11-09 ES ES02803360T patent/ES2249639T3/es not_active Expired - Lifetime
- 2002-11-09 AU AU2002366194A patent/AU2002366194B8/en not_active Ceased
- 2002-11-09 DE DE60206652T patent/DE60206652T2/de not_active Expired - Fee Related
- 2002-11-09 CA CA002467551A patent/CA2467551A1/en not_active Abandoned
- 2002-11-09 RU RU2004118423/04A patent/RU2295523C2/ru not_active IP Right Cessation
- 2002-11-09 MX MXPA04004683A patent/MXPA04004683A/es active IP Right Grant
- 2002-11-14 PA PA20028557901A patent/PA8557901A1/es unknown
- 2002-11-14 TW TW091133382A patent/TW200407137A/zh unknown
- 2002-11-15 PE PE2002001103A patent/PE20030715A1/es not_active Application Discontinuation
- 2002-11-15 AR ARP020104398A patent/AR037528A1/es not_active Application Discontinuation
- 2002-11-18 UY UY27543A patent/UY27543A1/es not_active Application Discontinuation
- 2002-11-18 GT GT200200233A patent/GT200200233A/es unknown
Also Published As
Publication number | Publication date |
---|---|
EP1448196A1 (en) | 2004-08-25 |
AR037528A1 (es) | 2004-11-17 |
AU2002366194B8 (en) | 2006-11-16 |
RU2295523C2 (ru) | 2007-03-20 |
ES2249639T3 (es) | 2006-04-01 |
JP4216192B2 (ja) | 2009-01-28 |
CA2467551A1 (en) | 2003-05-30 |
JP2005515980A (ja) | 2005-06-02 |
AU2002366194B2 (en) | 2006-10-26 |
CN100346792C (zh) | 2007-11-07 |
EP1448196B1 (en) | 2005-10-12 |
KR100577109B1 (ko) | 2006-05-10 |
DE60206652D1 (de) | 2006-02-23 |
PA8557901A1 (es) | 2003-06-30 |
DE60206652T2 (de) | 2006-06-22 |
PL369470A1 (en) | 2005-04-18 |
WO2003043634A1 (en) | 2003-05-30 |
BR0214221A (pt) | 2004-09-21 |
MXPA04004683A (es) | 2004-08-12 |
UY27543A1 (es) | 2003-05-30 |
AU2002366194A1 (en) | 2003-06-10 |
CN1589146A (zh) | 2005-03-02 |
TW200407137A (en) | 2004-05-16 |
US6599901B1 (en) | 2003-07-29 |
PE20030715A1 (es) | 2003-08-29 |
RU2004118423A (ru) | 2006-01-10 |
KR20050044537A (ko) | 2005-05-12 |
ATE306265T1 (de) | 2005-10-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GT200200240A (es) | Derivados de benzotiazol | |
GT200200233A (es) | Derivados de piridona de benzotiazol | |
GT200200220AA (es) | Nuevos derivados de pirrolidina | |
GT200200122A (es) | Imidazotriazinas | |
GT200600430A (es) | Compuestos de carboxiamina y metodos de uso de los mismos | |
GT200300177A (es) | Terapia de combinacion para enfermedades hiperproliferativas | |
GT200300171A (es) | Derivados de heterobiarilo como inhibidores de metaloproteinasa de la matriz | |
GT200400032A (es) | Nuevos compuestos heteroaromaticos condensados que son inhibidores del factor de crecimiento transformante (tgf) | |
GT200200027A (es) | Pirimidinas biciclicas como inhibidores de metaloproteinasas de matriz | |
GT200300226A (es) | 4-piperazinilbencenosulfonilindoles y usos de los mismos | |
NI200600094A (es) | Compuesto heterociclicos fusionados | |
GT200500008A (es) | Intermediarios de quinolina como inhibidores de receptores de tirosina quinasas y la sintesis de los mismos | |
GT200300093A (es) | Inhibidores de metaloproteinasa de heteroariloxi-aril-espiro-pirimidina-2,4,6-triona n-sustituida | |
GT200200121A (es) | Derivados aromaticos de acidos dicarboxilicos | |
GT200300187A (es) | Compuestos antiinflamatorios de di y trifluoro-triazolo-piridinas | |
GT200300268A (es) | Nuevos derivados fluoroglucosidos heterociclicos, medicamentos que contienen estos compuestos y el uso de los mismos | |
GT200200014A (es) | Inhibidores de piridina de metaloproteinasas de la matriz | |
GT200300138A (es) | Moduladores del receptor de glucocorticoides | |
BR0214024A (pt) | Derivados de 1,2,4-tiadiazol como moduladores de receptor de melanocortina | |
GT200400133AA (es) | Derivados de pirrolo[3,4-c] pirazol, activos como inhibidores de quinasa, proceso para su preparacion y composiciones farmaceuticas que los comprenden. (solicitud fraccionaria no. 1, derivada de la patente no. pi-2004-0133). | |
GT200300072A (es) | Aminoacidos con afinidad por la proteina alfa-2-delta. | |
GT200200216A (es) | Derivados del 3-azabiciclo [3.1.0] hexano | |
GT200500228A (es) | Prodroga de benzoxazoles sustituidos como agentes estrogenicos | |
GT200300258A (es) | Activadores de ppar | |
GT200300108A (es) | Derivados de benzoxazina y usos de los mismos |